Literature DB >> 16421964

Early metabolism evaluation making traditional Chinese medicine effective and safe therapeutics.

Yong Liu1, Ling Yang.   

Abstract

Increasing attention is being paid to the scientific evaluation of traditional Chinese medicine (TCM). As many TCMs are capable of biotransformation in the gastrointestinal tract, attention to biotransformation of TCM in the gastrointestinal tract may lead to discovery of the active components and active mechanisms. In this article, we review reports that host metabolic enzymes and intestinal bacteria may be responsible for the metabolism of TCM. Good understanding of the in vivo course of TCM will help us to know how to conduct metabolism evaluation of TCM by using in vitro human-derived system. This evaluation system will create new views on TCM as effective and safe therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421964      PMCID: PMC1363752          DOI: 10.1631/jzus.2006.B0099

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  45 in total

1.  ADME/PK as part of a rational approach to drug discovery.

Authors: 
Journal:  Drug Discov Today       Date:  2000-09       Impact factor: 7.851

Review 2.  The small intestine as a xenobiotic-metabolizing organ.

Authors:  Laurence S Kaminsky; Qing-Yu Zhang
Journal:  Drug Metab Dispos       Date:  2003-12       Impact factor: 3.922

Review 3.  Herbal remedies.

Authors:  Peter A G M De Smet
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

Review 4.  Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.

Authors:  Magnus Ingelman-Sundberg
Journal:  Trends Pharmacol Sci       Date:  2004-04       Impact factor: 14.819

5.  Long-term primary cultures of adult human hepatocytes.

Authors:  J B Ferrini; L Pichard; J Domergue; P Maurel
Journal:  Chem Biol Interact       Date:  1997-11-06       Impact factor: 5.192

Review 6.  Application of human liver microsomes in metabolism-based drug-drug interactions: in vitro-in vivo correlations and the Abbott Laboratories experience.

Authors:  A D Rodrigues; S L Wong
Journal:  Adv Pharmacol       Date:  1997

7.  Metabolism of paeoniflorin and related compounds by human intestinal bacteria. II. Structures of 7S- and 7R-paeonimetabolines I and II formed by Bacteroides fragilis and Lactobacillus brevis.

Authors:  Y Z Shu; M Hattori; T Akao; K Kobashi; K Kagei; K Fukuyama; T Tsukihara; T Namba
Journal:  Chem Pharm Bull (Tokyo)       Date:  1987-09       Impact factor: 1.645

8.  The metabolism of sennosides A and B by the intestinal microflora: in vitro and in vivo studies on the rat and the mouse.

Authors:  M Dreessen; H Eyssen; J Lemli
Journal:  J Pharm Pharmacol       Date:  1981-10       Impact factor: 3.765

9.  Characterization of human small intestinal cytochromes P-450.

Authors:  Q Y Zhang; D Dunbar; A Ostrowska; S Zeisloft; J Yang; L S Kaminsky
Journal:  Drug Metab Dispos       Date:  1999-07       Impact factor: 3.922

10.  Intestinal bacterial metabolism of flavonoids and its relation to some biological activities.

Authors:  D H Kim; E A Jung; I S Sohng; J A Han; T H Kim; M J Han
Journal:  Arch Pharm Res       Date:  1998-02       Impact factor: 4.946

View more
  2 in total

1.  Interaction of the main components from the traditional Chinese drug pair Chaihu-Shaoyao based on rat intestinal absorption.

Authors:  Yan Chen; Jinyan Wang; Ling Yuan; Lei Zhou; Xiaobin Jia; Xiaobin Tan
Journal:  Molecules       Date:  2011-11-17       Impact factor: 4.411

2.  Drug-Drug Interactions Potential of Icariin and Its Intestinal Metabolites via Inhibition of Intestinal UDP-Glucuronosyltransferases.

Authors:  Yun-Feng Cao; Rong-Rong He; Jun Cao; Jian-Xing Chen; Ting Huang; Yong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-16       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.